Multisite Cannulation for Venovenous Extracorporeal Membrane Oxygenation Support in Neonates and Infants: Extracorporeal Life Support Database Study, 2013–2023
Jon Lillie, Shane M. Tibby, Peter Rycus, Marc Anders, Gail Annich, Matteo Di Nardo, Geoff Burnhill,OBJECTIVES:
We have evaluated the complications and outcomes of venovenous multisite (VVMS) cannulation for support with extracorporeal membrane oxygenation (ECMO) using the Extracorporeal Life Support Organization (ELSO) registry of neonates (≤ 28 d old) and infants (29–364 d old).
DESIGN:
Retrospective ELSO database cohort, comparing outcomes and complications associated with VVMS and venovenous dual lumen (VVDL) cannulation.
PATIENTS:
Patients younger than 1 year supported with VV ECMO.
SETTING:
ELSO data January 1, 2013 to December 31, 2023.
INTERVENTIONS:
None.
MEASUREMENTS AND MAIN RESULTS:
We identified 1403 neonates and 603 infants supported with VVDL, and 42 and 77, respectively, with VVMS. At 24 hours of ECMO we found median (interquartile range [IQR]) oxygen saturations (Sa
CONCLUSIONS:
Between 2013 and 2023, in neonatal and infant ECMO, VVMS as opposed to VVDL cannulation was associated with higher ECMO flows and Sa